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Abstract: Low HDL-cholesterol (HDL-C), using as cut-offs 1.03 mmol/L in men and 
1.29 mmol/L in women, was observed in more than 25% apparently healthy adults  
(n = 541) in a cross-sectional study on nutrition transition and cardiometabolic risk factors 
(CMRF) in Benin, West Africa. Both overweight/obesity (35.3%) and underweight 
(11.3%) were present, displaying the double burden of malnutrition. We examined in more 
depth the association of low HDL-C with nutrition and with other CMRF. Metabolic 
syndrome components were assessed, plus the ratio of total cholesterol (TC)/HDL-C and 
serum homocysteine. Insulin resistance was based on Homeostasis Model Assessment. We 
also measured BMI and body composition by bio-impedance. Dietary quality was 
appraised with two non-consecutive 24 h recalls. Low HDL-C was associated with much 
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higher TC/HDL-C and more abdominal obesity in men and women and with more insulin 
resistance in women. The rate of low HDL-C was highest (41.9%) among the 
overweight/obese subjects (BMI ≥ 25), but it also reached 31.1% among the underweight 
(BMI < 18.5), compared with 17.3% among normal-weight subjects (p < 0.001). Lower 
dietary micronutrient adequacy, in particular, in vitamins A, B3, B12, zinc and calcium, was 
associated with low HDL-C when controlling for several confounders. This suggests  
that at-risk lipoprotein cholesterol may be associated with either underweight or 
overweight/obesity and with poor micronutrient intake. 
Keywords: HDL-cholesterol; West Africa; metabolic syndrome; dietary quality; 
nutritional status; double burden of malnutrition; lifestyle; nutrition transition 
 
1. Introduction 
Low income countries undergoing a rapid transition towards Western dietary patterns and sedentary 
lifestyles [1] are now facing the double burden of malnutrition, that is, the coexistence in the same 
population of ―undernutrition‖ and ―overnutrition‖ [2]. Undernutrition encompasses general and 
specific nutritional deficiencies, while overnutrition refers to obesity and other nutrition-related  
non-communicable diseases (NCDs). NCDs are indeed a growing concern in developing countries, and 
WHO has invited countries to invest in the prevention of obesity, diabetes, cardiovascular  
disease (CVD) and some types of cancer [3]. Priority actions have been proposed at the NCD Summit 
of 2011 [4]. 
Dyslipidaemia is a major risk factor for CVD across population groups, as was shown in the 
INTERHEART Study [5]. It is part of the metabolic syndrome (MetS), an aggregation of  
cardio-metabolic risk factors (CMRF) that include insulin resistance, hyperglycemia, high blood 
pressure and abdominal obesity [6]. In the MetS, dyslipidaemia is defined as high triglyceride 
concentrations or low HDL-cholesterol (HDL-C). Low HDL-C is a well-established and independent 
CMRF [7]. The antiatherogenic properties of HDL-C are related to its role in reverse cholesterol 
transport, endothelial cell function regulation and inhibition of oxidation, thrombosis and inflammation 
through complex intracellular signalling pathways [7,8]. In diabetic subjects, low HDL-C is an 
independent risk factor for the development of macrovascular, as well as microvascular  
complications [9]. 
Low HDL-C is associated with increasing risk of CVD with advancing age, perhaps even more so 
among women, and weight gain appears to be the main culprit of low HDL-C [10,11]. A high 
prevalence of low HDL-C among adults has been reported as the most prevalent lipid abnormality in 
Mexicans [12]. Turks and other Asians, including Bangladeshi and Pakistani populations, have among 
the highest prevalence rates of low HDL-C worldwide [13]. In African and African-descent 
populations, total cholesterol and triglycerides are usually lower than in Caucasians, with an associated 
lower coronary risk. However, low HDL-C is a common feature of MetS in these populations [14–17]. 
While genetic factors are major determinants of HDL-C, environmental factors, such as alcohol 
consumption, tobacco, physical activity, diet and obesity are also at play [18]. Interestingly, 
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vegetarians, whose intake of saturated and unsaturated fat is limited, have low HDL-C, but a low 
cardiovascular risk [18]. The rather high occurrence of low HDL-C in Africans and other developing 
country populations might be associated with low fat intake, other dietary inadequacies and 
undernutrition, but this is not well documented in spite of its relevance for countries facing the double 
burden of malnutrition. 
In the Benin study, we indeed observed that low HDL-C was highly prevalent, while 
hypertriglyceridaemia and high low-density lipoprotein cholesterol (LDL-C) were uncommon [19,20]. 
The rate of low HDL-C (<1.03 in men; <1.29 in women [6]) was 22.5% in men and 32.6% in women. 
Low HDL-C was the MetS component exhibiting the highest prevalence in this population. Similar 
findings were also reported in apparently healthy adults of Ouagadougou, the capital city of Burkina 
Faso, with 28% of men and 32% of women having low HDL-C [21]. Examining this intriguing feature 
of the MetS in Benin was therefore deemed relevant. Additionally, in the Benin study, 12.5% of men 
and 10% of women were underweight, whereas 19.9% of men and 50.7% of women were overweight, 
including 4.4% obese men and 22.2% of obese women. This was an opportunity to examine nutritional 
determinants and cardiometabolic correlates of low HDL-C in more depth, in this context of the double 
burden of malnutrition. The working hypothesis was that low HDL-C would also occur in 
undernutrition and not only overnutrition. 
―Overnutrition‖ is somewhat a misnomer, because dietary imbalance and not only excess may be 
associated with NCDs. Malnutrition is generally perceived as a synonym for undernutrition, and it 
would seldom be equated with ―overnutrition‖. For this reason, the term ―dysnutrition‖ may be more 
relevant than ―malnutrition‖ to encompass the whole range of nutritional disorders, from general 
undernutrition or specific micronutrient deficiencies, to diet-related NCDs [22]. ―Dysnutrition‖ is not 
as yet accepted, however. In the present paper, undernutrition and overnutrition refer to either 
anthropometric status or dietary intakes, whereas underweight and overweight/obesity refer 
exclusively to anthropometric status. 
2. Experimental Section 
2.1. Subjects and Study Design 
This cross-sectional Benin study was conducted in Cotonou, the largest city in the country, in 
Ouidah, a small-size city located 50 km away from Cotonou (semi-urban area) and in the rural area 
surrounding Ouidah. Subjects (n = 541) were randomly selected by multistage sampling in the urban  
(n = 200), semi-urban (n = 171) and rural (n = 170) areas, using census data (urban) or after 
enumeration of compounds (semi-urban and rural). Eligible participants were Beninese-born adults 
aged 25 to 60, having lived in the study area for at least six months. Subjects with a prior diagnosis of 
hypertension, diabetes or cardiac condition were excluded, because of possible modification of their 
diet and lifestyle, but the cases detected after the study began were retained in data analyses. As 
dyslipidemia is not diagnosed as such, it was not an exclusion criterion, as it would unlikely affect 
people’s diet. Data were collected between 2006 and 2008. Details of study protocol may be found 
elsewhere [19,23–25]. 
Nutrients 2013, 5 1369 
 
 
The study was approved by the Ethics Committee of the Faculty of Medicine, University of 
Montreal, and by the Ministry of Health in Benin. 
2.2. Biological and Biochemical Variables 
Anthropometric variables included body weight, height and waist circumference measured 
according to standard procedures. BMI cut-offs for underweight (<18.5), overweight (25–29.9) and 
obesity (≥30) were as defined by WHO [26]. Waist circumference (WC) was measured as index of 
abdominal obesity [27]. Fat mass and fat-free mass (FFM) were computed by bioelectric impedance 
using sex and ethnicity-specific equations [28]. Blood pressure was measured as described 
previously [23]. Blood samples were collected after a 12-h overnight fast and were stored in ice boxes 
until centrifugation within two hours. Fasting plasma glucose and serum concentrations of total 
cholesterol (TC), LDL-C, HDL-C and triglycerides were determined using standard laboratory 
methods. The ratio of TC/HDL-C was computed. MetS components were as defined in the joint 
statement of International Diabetes Federation (IDF) taskforce [6]: abdominal obesity (WC ≥ 80 cm in 
women and ≥94 cm in men); elevated triglycerides (>1.70 mmol/L); high blood pressure  
(≥130/85 mmHg); high fasting glucose (≥5.6 mmol/L); and low HDL-C (≤1.29 mmol/L in women and 
≤1.03 mmol/L in men). The insulin resistance cut-off was the seventy-fifth centile of Homeostasis 
Model Assessment (HOMA) in the whole sample of Benin subjects, as advocated [29]. HOMA at the 
seventy-fifth centile in the Benin study was 3.2. The selected cut-off for high TC/HDL-C was 4 for 
men and 5 for women [30]. Serum homocysteine was determined with ELISA (Axis
®
 Homocysteine, 
Hamburg, Germany), and the cut-off was 12 µmol/L [31]. 
2.3. Socio-Economic and Demographic Variables 
Socio-economic and demographic data were collected in individual interviews. The level of 
education was assessed. Socio-economic status (SES) was based on a household amenity score as 
proxy for income, as used in several Demographic and Health Surveys in Africa. The items include 
type of housing, material possessions and utilities. The SES score was computed separately in each 
location and tertiles were used in the analyses. Details of items and coding are available  
elsewhere [19,23–25]. 
2.4. Dietary Quality 
Dietary intake was computed on the basis of two or three non-consecutive 24-h food recalls 
conducted over an average period of one month. Diet quality was appraised with a micronutrient 
adequacy score and a preventive diet score developed by our group for international use. The 
micronutrient score was based on adequacy of intake of 14 micronutrients (vitamins A, B6, B12, C and E, 
thiamine, riboflavin, niacin, pantothenic acid, folate, magnesium, calcium, iron and zinc) according to 
WHO/FAO recommended dietary intakes for age and sex [32]. The preventive diet score was based on 
compliance with eight WHO/FAO dietary guidelines for the prevention of chronic diseases (% total 
fat, % saturated fatty acids, % polyunsaturated fatty acids, cholesterol (mg/day), % sugar, % protein, 
fiber (g/day), as well as fruits and vegetables (g/day)) [33]. For each item, a rating of ―1‖ was given if 
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the intake met the recommendation and ―0‖ if it did not. Further details on dietary methods were 
previously published [25]. 
2.5. Alcohol Consumption and Smoking 
Subjects were asked about their usual drinking patterns. An alcohol consumption score was based 
on the pattern of alcohol consumption and the mean quantity of alcohol consumed daily. Three 
categories were identified: non-drinkers, moderate alcohol consumption and heavy drinkers. Smoking 
habits were defined as: current smokers, ex-smokers and non-smokers. For alcohol and tobacco, the 
questionnaire was based on the STEPwise tool developed by WHO [34]. 
2.6. Physical Activity 
Physical activity was assessed through three non-consecutive 24-h recalls [24]. Participants were 
asked about all their previous day activities, from the time they got up to the moment they went to bed. 
Time spent in bed, in various modes of transportation, for main and secondary occupations, for house 
chores and for leisure activities was computed from the daily estimated schedule. The intensity level of 
each activity was estimated in metabolic equivalents (MET). Based on WHO guidelines for the 
prevention of chronic diseases [33], we described subjects as active (≥3 MET and ≥30 min/day) and 
inactive (<30 min/day or <3 MET). 
2.7. Statistical Analyses 
Data were analyzed using IBM SPSS, version 19.0. The independent contribution of lifestyle and 
dietary factors to HDL-C was assessed in multivariate regression models controlling for  
socio-economic and demographic variables. The interaction of sex by zone was examined to verify 
whether the association of sex with HDL-C was modulated by the rural, semi-urban or urban location. 
Univariate statistics used as appropriate t-tests and chi
2
 with odds ratios (ORs). ORs of  
cardio-metabolic risk factors in low HDL-C compared to normal HDL-C were computed. The level of 
statistical significance was a p value of <0.05. 
3. Results 
The data on the 541 subjects (50% women) of the Benin study were used in the analyses. The 
results are broken down according to HDL-C status. 
3.1. Socio-Economic Characteristics 
As seen in Table 1, residence area was significantly associated with HDL-C, with a significantly 
lower rate of low HDL-C in the semi-urban group compared to the rural and the urban groups. Age, 
education and SES were unrelated to HDL-C status in these univariate analyses. 
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Table 1. Subjects’ characteristics according to high-density lipoprotein cholesterol  
(HDL-C) level. 
 (n) Low HDL-C (%) Normal HDL-C (%) p 
1
 
Gender    <0.01 
Women 
Men 
All 
(270) 
(271) 
(541) 
32.6 
22.5 
27.5 
67.4 
77.5 
72.5 
 
Age category    0.78 
25–34 years 
35–44 years 
45 years+ 
(209) 
(225) 
(107) 
27.8 
26.2 
29.9 
72.2 
73.8 
70.1 
 
Residence area    <0.001 
Rural 
Semi-urban 
Urban (Cotonou) 
(170) 
(171) 
(200) 
25.3 
18.1 
37.5 
74.7 
81.9 
62.5 
 
Education    0.39 
None 
Primary school 
High school 
(138) 
(187) 
(216) 
28.3 
24.1 
30.1 
71.7 
75.9 
69.9 
 
SES score tertile    0.25 
Low 
Middle 
High 
(186) 
(195) 
(160) 
23.1 
29.7 
30.0 
76.9 
70.3 
70.0 
 
1
 Chi
2
. 
3.2. Serum Lipid and Body Composition 
Low HDL-C was associated in men and women with significantly higher values for TC/HDL-C, 
BMI and WC (Table 2). In both men and women, LDL-C was normal and showed no association with 
HDL-C level. In women only, low HDL-C was also associated with significantly higher triglyceride 
concentrations, higher fat-free body mass and higher body fat mass. Table 2 also shows than mean 
BMI was normal in men, but elevated in women. 
3.3. Nutritional (Anthropometric) Status, Diet Quality and Lifestyle 
BMI and WC status, dietary quality scores and lifestyle patterns are presented in Table 3 according 
to HDL-C level, for men and women. Anthropometric status was significantly associated with HDL-C 
in men and women. Overweight/obesity and abdominal obesity were much more widespread in women 
than men. Not only were overweight/obesity and abdominal obesity associated with low HDL-C, but 
so was underweight. Overall, the rate of low HDL-C was highest among the overweight/obese (41.9% 
of the 191 overweight-obese subjects), but it also reached 31.1% of the 61 underweight subjects, 
compared with 17.3% of the 289 normal-weight subjects (p < 0.001). The same trend was observed in 
men and women. Abdominal obesity (high WC) was significantly associated with low HDL-C. 
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Table 2. Serum lipid and body composition according to HDL-C level. LDL-C, low-density lipoprotein cholesterol. 
 
Men Women 
All  
(n = 271) 
Low HDL-C  
(n = 61) 
Normal HDL-C  
(n = 210) 
p 
1 All  
(n = 270) 
Low HDL-C  
(n = 88) 
Normal HDL-C  
(n = 182) 
p 
Ratio TC/HDL-C 3.37 ± 1.26 4.46 ± 1.53 3.05 ± 0.96 <0.001 3.21 ± 1.06 4.13 ± 1.10 2.76 ± 0.69 <0.001 
LDL-C 2.53 ± 0.98 2.52 ± 1.01 2.53 ± 0.98 0.91 2.64 ± 0.91 2.78 ± 0.88 2.57 ± 0.93 0.085 
Triglycerides mmol/L 0.81 ± 0.46 0.89 ± 0.42 0.79 ± 0.46 0.14 0.69 ± 0.33 0.82 ± 0.34 0.63 ± 0.30 0.001 
Body Mass Index 22.3 ± 3.8 23.4 ± 4.2 21.9 ± 3.6 0.008 26.0 ± 6.1 28.2 ± 7.2 25.0 ± 5.2 <0.001 
Waist circumference 82.2 ± 10.4 84.9 ± 11.3 81.4 ± 10.1 0.022 88.0 ± 13.7 92.6 ± 15.2 85.7 ± 12.3 <0.001 
Fat-free mass kg 55.6 ± 7.7 56.7 ± 8.6 55.2 ± 7.4 0.18 44.6 ± 6.3 47.0 ± 7.3 43.5 ± 5.4 <0.001 
Fat mass kg 11.4 ± 6.6 12.6 ± 6.7 11.1 ± 6.6 0.11 22.2 ± 11.7 26.0 ± 13.8 20.4 ± 10.0 <0.001 
1
 t-test. 
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Table 3. Nutritional status, diet quality and lifestyle according to HDL-C level. 
 
Women  Men 
(n) Low HDL-C (%) Normal HDL-C (%) p 
1
  (n) Low HDL-C (%) Normal HDL-C (%) p 
BMI status 
2
    <0.001     <0.001 
Underweight (27) 33.3 66.7   (34) 29.4 70.6  
Normal weight (106) 18.9 81.1   (183) 16.4 83.6  
Overweight/ obese (137) 43.1 56.9   (54) 38.9 61.1  
WC status 
3
    0.023     0.045 
Abdominal obesity (187) 36.9 63.1   (37) 35.1 64.9  
Normal WC (83) 22.9 77.1   (234) 20.5 79.5  
Micronutrient intake adequacy   0.10     0.04 
1st tertile (113) 34.5 65.5   (83) 31.3 68.7  
2nd tertile (93) 37.6 62.4   (76) 22.4 77.6  
3rd tertile (64) 21.9 78.1   (112) 16.1 83.9  
Preventive diet score   0.35     0.95 
1st tertile (75) 37.3 62.7   (74) 23.0 77.0  
2nd tertile (133) 33.1 66.9   (126) 23.0 77.0  
3rd tertile (62) 25.8 74.2   (71) 21.1 78.9  
Physical activity 
4 
   <0.001     0.65 
Inactive (69) 50.7 49.3   (27) 25.9 74.1  
Active (201) 26.4 73.6   (244) 22.1 77.9  
Alcohol consumption   0.08     0.67 
None (171) 31.0 69.0   (93) 21.5 78.5  
Moderate (72) 29.2 70.8   (97) 20.6 79.4  
High (27) 51.9 48.1   (81) 25.9 74.1  
1 
Chi
2
; 
2
 Underweight: BMI < 18.5; normal weight: BMI 18.5–24.9; overweight/obese: BMI ≥ 25; 3 Abdominal obesity: WC ≥ 80 cm in men, ≥94 cm in women;  
4
 Active: ≥half-hour/day of moderate or vigorous physical activity. 
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Regarding dietary quality, a higher micronutrient adequacy score was associated with a lower rate 
of low HDL-C in women; the trend was not significant in men. The preventive diet score showed no 
relationship with HDL-C. The proportion of low HDL-C was significantly lower among the physically 
active than inactive men. In women, physical activity did not appear to be significantly related to  
HDL-C. A higher consumption of alcohol tended to be associated with lower HDL-C, but only in men. 
Mean percent intake adequacy for individual micronutrients included in the micronutrient score is 
displayed in Table 4 according to HDL-C level. Intakes of vitamin A, niacin, vitamin B12, zinc and 
calcium were significantly better in those with normal HDL-C level, thus explaining the higher 
micronutrient scores of the latter compared to subjects with low HDL-C. Of note, percent adequacy 
was lowest for vitamin B12. When the data were analyzed by sex, micronutrient adequacy according to 
HDL-C level was significant in both men and women for zinc. In women, adequacy percentages for 
vitamin A, vitamin E and vitamin B12 adequacy were also significant, while in men, vitamin C and 
calcium were (data not shown). 
Table 4. Micronutrient intake adequacy % according to HDL-C level. 
 All Low HDL-C Normal HDL-C p 
1 
Vitamin A 99.5 ± 4.3 98.8 ± 6.9 99.7 ± 2.7 0.019 
Vitamin E 73.3 ± 22.5 72.6 ± 23.2 73.6 ± 22.1 0.640 
Vitamin C 99.8 ± 2.3 99.6 ± 3.3 99.9 ± 1.7 0.203 
Thiamine 99.0 ± 4.3 98.5 ± 5.2 99.2 ± 3.9 0.099 
Riboflavin 95.2 ± 10.6 94.4 ± 11.3 95.4 ± 10.3 0.319 
Niacin 97.6 ± 7.5 96.3 ± 9.2 98.0 ± 6.7 0.017 
Vitamin B12 66.4 ± 26.6 61.7 ± 25.6 68.2 ± 26.7 0.011 
Vitamin B6 99.8 ± 1.8 99.9 ± 1.8 99.8 ± 1.9 0.808 
Folate 94.6 ± 11.8 94.0 ± 12.1 94.8 ± 11.7 0.497 
Pantothenic acid 95.8 ± 9.5 94.9 ± 10.1 96.1 ± 9.2 0.193 
Magnesium 100 ± 0.29 100 ± 0.0 100 ± 0.34 0.538 
Zinc 87.6 ± 15.8 84.3 ± 16.5 88.8 ± 15.4 0.003 
Iron 86.4 ± 20.2 83.9 ± 21.7 87.3 ± 19.6 0.084 
Calcium 84.5 ± 22.4 79.4 ± 24.3 86.4 ± 21.4 0.001 
Micronutrient adequacy 
score (maximum 14) 
10.0 ± 2.7 9.4 ± 2.7 10.2 ± 2.6 0.001 
1
 t test. 
3.4. Diet and Lifestyle Determinants of HDL-C 
The multiple linear regression model of HDL-C on lifestyle and dietary factors controlling for 
socio-demographic variables (Table 5) showed that a higher micronutrient adequacy score was 
independently and positively associated with higher HDL-C. Micronutrient adequacy was also 
significantly and negatively associated with the ratio of TC/HDL-C when the latter was substituted for 
HDL-C as a dependent variable (data not shown). The preventive diet score and other lifestyle 
parameters were not significant predictors of HDL-C (or TC/HDL-C). Tobacco smoking was not 
included in the models, because very few men smoked and women did not smoke. WC tended to be 
negatively associated with HDL-C, while being significantly and positively associated with  
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TC/HDL-C (data not shown). BMI was not significant in this model, since its relationship with HDL-C 
was not linear. Sex, age and residence area were significant determinants, but there was no interaction 
of sex and location. 
Table 5. Linear regression of HDL-C on dietary and lifestyle factors controlling for  
socio-economics. 
 
HDL-C 
β (standardized) p 
Sex (0 = M; 1 = F) 0.18 0.015 
Age years 0.12 0.01 
Zone (0 = rural; 1 = semi-urban; 2 = urban) −0.145 0.025 
Education (0 = none; 1 = primary; 2 = secondary+) 0.045 0.37 
Household amenity score tertile −0.041 0.37 
Alcohol consumption (g/day) 0.025 0.57 
Physical activity (0 = None; 1 ≥ 30 min/day) 0.086 0.08 
Micronutrient intake adequacy score (0–14) 0.125 0.01 
Preventive diet score (0–8) −0.004 0.91 
BMI −0.009 0.70 
Waist circumference −0.165 0.10 
Interaction sex by zone 0.046 0.59 
R
2
 of model  0.130 <0.001 
3.5. Association of HDL-C with Other Cardiometabolic Risk Factors 
Table 6 shows the proportion of men and women exhibiting CMRF according to their HDL-C status 
and the odds ratios (OR) for individual and clustered CMRF in low HDL-C groups. The CMRF 
considered are those of the MetS, and we added hyperhomocysteinaemia and TC/HDL-C. The odds 
ratio (OR) for insulin resistance was significant in women, with a higher rate in subjects with low 
HDL-C; a similar trend was observed in men, but it was not significant. The ORs for elevated 
TC/HDL-C ratio were significant in men and women, with a several-fold increased likelihood of a 
high ratio when HDL-C was low. Even though high triglyceride concentrations were not highly 
prevalent in this population, we observed in women an increased rate with low HDL-C. The other 
individual CMRF examined in the study, that is, high blood pressure, high serum homocysteine and 
elevated fasting glycaemia, were not significantly associated with HDL-C. The OR for the MetS in 
subjects with low HDL-C was significant in women, but not in men. When only the MetS risk factors 
other than low HDL-C were combined (high blood pressure; elevated fasting glycaemia; high 
triglyceride concentration; abdominal obesity), the likelihood of clustering of at least two risk factors 
was not significantly higher in low HDL-C men or women. 
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Table 6. Prevalence and odds of cardio-metabolic risk factors in low HDL-C subjects. 
 
Men Women 
Low HDL-C 
(%) 
Normal HDL-C 
(%) 
OR (95% CI) 
1
 
Low HDL-C 
(%) 
Normal HDL-C 
(%) 
OR (95% CI) 
1 
High blood pressure  14.8 25.7 0.50 (0.23–1.08) 23.9 25.8 0.90 (0.50–1.63) 
Insulin resistance  21.3 15.2 1.51 (0.73–3.09) 46.6 27.5 2.30 (1.36–3.91) 
Hyperhomocysteinaemia 44.3 54.6 0.66 (0.37–1.17) 27.6 23.3 1.25 (0.70–2.24) 
Elevated fasting glycaemia 8.2 10.0 0.80 (0.29–2.23) 8.0 9.3 0.84 (0.33–2.10) 
High ratio TC/HDL-C 26.2 4.8 7.11 (3.03–16.70) 2 52.3 4.4 23.82 (10.5–54.2) 
High triglyceride concentration 3.3 3.3 0.98 (0.20–4.86) 2.3 0.0 3 
Abdominal obesity 21.3 11.4 2.10 (0.996–4.42) 78.4 64.8 1.97 (1.09–3.56) 
MetS 
4
 9.8 1.4 2.4 (0.94–5.98) 28.4 3.3 3.8 (1.85–7.84) 
≥2 MetS components other 
than low HDL-C 
14.8 10.5 1.48 (0.64–3.41) 28.4 25.3 1.17 (0.66–2.08) 
1
 OR = odds ratio for the risk factor(s) in low HDL-C subjects; CI = confidence intervals; 
2
 Significant (p < 0.05) values in bold; 
3
 cannot be computed;  
4
 MetS = metabolic syndrome. TC = total cholesterol. 
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4. Discussion 
The Benin study on nutrition transition and CMRF reported previously that the main components of 
the MetS present in the Benin population were high blood pressure, low HDL-C and abdominal 
obesity [20], in accordance with other studies in West Africa [17] and in black South Africans [16]. 
4.1. Low HDL-C at Both Ends of the BMI Continuum? 
We found that both underweight and overweight as nutritional status indicators tended to be 
associated with low HDL-C. The rate of low HDL-C according to BMI status indeed showed a  
J-curve. This suggests that chronic energy deficiency reflected in low BMI and not only overweight 
may be associated with enhanced cardio-metabolic risk, because of low HDL-C. The evidence of an 
inverse relationship between HDL-C and cardio-metabolic risk is robust. In a review, 31 out of  
58 prospective studies showed a significant inverse association of HDL-C with CVD risk, even when 
controlling for other lipid factors [35]. In our study, low HDL-C was associated with higher odds for 
other CMRF, such as high TC/HDL-C ratio and insulin resistance (among women).  
Low HDL-C and other blood lipid alterations have been reported in malnourished children [36,37]. 
To our knowledge, ours is one of the first studies in adults to consider the dual burden of malnutrition, 
that is, the coexistence in the same individuals of undernutrition or micronutrient malnutrition and  
diet-related chronic disease risk factors. The double burden of malnutrition has usually been examined 
at population or household level, rather than in individuals [38]. Furthermore, the more commonly 
described individual phenotype of dual burden is the coexistence of overweight and micronutrient 
malnutrition [39], or else, of stunted height and hypertension [40], not current underweight and chronic 
disease risk. Undernutrition in early life—in utero or in infancy—has also been associated with 
subsequent elevated risk for CVD, diabetes and abdominal obesity [41]; this represents the 
intergenerational form of the double nutritional burden [42]. 
We describe in this paper a phenotype of concurrent underweight and high-risk blood cholesterol 
profile (low HDL-C and high TC/HDL-C) in Benin. In Tanzania, lower HDL-C was reported in rural 
adults compared to city dwellers, whereas the other serum lipid components appeared less deteriorated 
in the rural subjects [43]. This is consistent with the association of low HDL-C with underweight, 
since it is more highly prevalent in rural areas of developing countries, as we also observed [24]. 
However, the significance and metabolic implications of low HDL-C in underweight vs. overweight 
individuals cannot be ascertained in this study. Further research is required to examine not only  
HDL-C and other cardio-metabolic risk factors in adults exposed to under- and over-nutrition, but also 
the functionality of HDL-C. 
4.2. Micronutrient Intake Independently Associated with HDL-C 
A major finding of our study is the observed independent association of lower micronutrient intake 
adequacy with lower HDL-C, when controlling for anthropometric status, socio-economic and 
demographic factors, physical activity and alcohol consumption, although only 13% of the variance of 
HDL-C was explained by the full regression model. Dietary data was obtained for two or three 24-h 
food recalls on non-consecutive days using the multiple pass method [44] for optimal quality of the 
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data. In our study, the micronutrient adequacy score was consistently protective, whereas the 
preventive diet score was not, but this may be ascribed to the score itself or to local diets, which were 
not highly atherogenic even in the large city [25]. Micronutrient deficiencies are suspected to increase 
the risk of chronic diseases, and so far, there is some evidence in humans primarily for folate, vitamin 
B12, zinc and iron [45–48]. In our study, the micronutrient adequacy score, which included 14 vitamins 
and minerals, was positively associated with HDL-C level. Intake adequacy of five vitamins, including 
B12, but not folate, was significant. We also observed that intake adequacy of zinc and calcium was 
significant. This further suggests that undernutrition, whether general or micronutrient-specific, and 
not only overnutrition, increases cardio-metabolic risk. In our study in Burkina Faso [21,43], the 
double burden phenotypes combining micronutrient deficiencies and CMRF other than obesity were 
associated with dietary patterns characterized by low adequacy of vitamins B12 and B6, but not  
zinc [49]. Vitamin D deficiency has also been found to be related to lower HDL-C in women [50]. The 
observed associations between micronutrient deficiencies and HDL-C do not disclose putative 
biological mechanisms that could explain the links. However, the connection of micronutrients with 
chronic diseases has been a subject of research and hypotheses for several years [51]. 
HDL-C may decline as a result of poor nutrition (or low fat intake like in the vegetarians) and also 
because of inflammation and hyperhomocysteinaemia. While there is limited information, inflammation 
may be widespread and contribute to chronic disease in Africa [52]. In Benin, elevated homocysteine 
was highly prevalent (52.2% of men, 24.7% of women) [53], but we found no independent association 
with HDL-C. Even if HDL-C is high, its functionality may be altered in certain cardio-metabolic 
conditions, in which case HDL-C may not then fully play its protective role [54,55]. 
4.3. Low HDL-C and High TC/HDL-C as Markers of at-Risk Lipid Profile in Sub-Saharan Africans 
In our study, the overall prevalence of high TC/HDL-C was also high, although not as high as that 
of low HDL-C. Since high LDL-C was not frequent (7.8%; no difference between men and women), 
high ratios are likely ascribable to low HDL-C rather than elevated LDL-C. The odds for other CMRF 
in low-HDL-C subjects was indeed highest for elevated TC/HDL-C. In populations at risk of CVD 
because of low HDL-C, it was reported that TC/HDL-C ratio would identify more at-risk subjects than 
Framingham risk tables [56]. This suggests that TC/HDL-C could serve as single marker of an at-risk 
lipid profile in sub-Saharan Africans. 
The odds for insulin resistance were also significantly increased in low HDL-C subjects, at least in 
women, compared with individuals with normal HDL-C. However, no differences were detected in the 
occurrence of high blood pressure, hyperglycemia or hyperhomocysteinaemia. It would be tempting to 
speculate on the link between higher insulin resistance and inadequate zinc intakes, since both were 
observed in low HDL-C subjects in our study. Experimental studies in rats have shown that maternal 
zinc deficiency results in insulin resistance in the offspring [57], and the connection between zinc, the 
metabolic syndrome and diabetes is documented in humans [48]. 
4.4. Strengths and Limitations 
Among the strengths of the study, we will mention the collection of extensive data on diet and 
lifestyle, in addition to being one of the first studies to examine both ends of the nutrition continuum in 
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sub-Saharan African adults. The cross-sectional nature of the study is undoubtedly a limitation. 
Another limitation is that overweight and obese individuals had to be collapsed into a single group 
owing to small number of obese men. Regarding abdominal obesity, the WC cut-points recently 
proposed as predictors of MetS in black South Africans [58] may be relevant in further studies on 
cardiometabolic risk factors in sub-Saharan Africa, as ethno-specific WC cut-offs are advocated [6], 
but do not as yet exist for Africans. 
5. Conclusions 
The study on anthropometric nutritional status, diets and lifestyles and cardio-metabolic risk factors 
in apparently healthy Benin adults suggests that low HDL-C may also be associated with underweight 
and not only overweight/obesity. Additionally, poor micronutrient intakes, notably vitamin B12 and 
zinc, were significant and independent predictors of low HDL-C. A high ratio of TC/HDLC was 
strongly associated with low HDL-C, and it could be worth further assessing its value as a marker of 
cardiometabolic risk in sub-Saharan populations. The findings of this study will have to be confirmed 
in longitudinal studies, but they strongly suggest that in order to tackle diet-related chronic diseases in 
nutrition transitioning countries, the double burden of malnutrition needs to be addressed, that is, not 
only obesity, but also underweight and poor micronutrient nutrition. 
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